SS Innovations International (SSII) Competitors $5.80 -0.50 (-7.94%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SSII vs. GKOS, BLCO, SLNO, TMDX, NVST, LIVN, WRBY, INSP, LQDA, and LMATShould you be buying SS Innovations International stock or one of its competitors? The main competitors of SS Innovations International include Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. SS Innovations International vs. Its Competitors Glaukos Bausch + Lomb Soleno Therapeutics TransMedics Group Envista LivaNova Warby Parker Inspire Medical Systems Liquidia Technologies LeMaitre Vascular SS Innovations International (NASDAQ:SSII) and Glaukos (NYSE:GKOS) are both medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, media sentiment, profitability and risk. Do analysts rate SSII or GKOS? Glaukos has a consensus price target of $124.83, indicating a potential upside of 50.87%. Given Glaukos' stronger consensus rating and higher possible upside, analysts plainly believe Glaukos is more favorable than SS Innovations International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SS Innovations International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Glaukos 1 Sell rating(s) 2 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.79 Does the media favor SSII or GKOS? In the previous week, Glaukos had 7 more articles in the media than SS Innovations International. MarketBeat recorded 13 mentions for Glaukos and 6 mentions for SS Innovations International. Glaukos' average media sentiment score of 1.46 beat SS Innovations International's score of 0.96 indicating that Glaukos is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS Innovations International 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Glaukos 10 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SSII or GKOS more profitable? Glaukos has a net margin of -21.43% compared to SS Innovations International's net margin of -40.20%. Glaukos' return on equity of -8.59% beat SS Innovations International's return on equity.Company Net Margins Return on Equity Return on Assets SS Innovations International-40.20% -40.41% -20.80% Glaukos -21.43%-8.59%-6.61% Which has better earnings & valuation, SSII or GKOS? SS Innovations International has higher earnings, but lower revenue than Glaukos. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSS Innovations International$20.65M54.37-$19.15MN/AN/AGlaukos$432.95M10.96-$146.37M-$1.65-50.15 Do institutionals and insiders have more ownership in SSII or GKOS? 99.0% of Glaukos shares are held by institutional investors. 5.8% of Glaukos shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryGlaukos beats SS Innovations International on 12 of the 14 factors compared between the two stocks. Get SS Innovations International News Delivered to You Automatically Sign up to receive the latest news and ratings for SSII and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SSII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SSII vs. The Competition Export to ExcelMetricSS Innovations InternationalTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$1.12B$2.91B$26.33B$10.15BDividend YieldN/A1.61%2.77%4.61%P/E RatioN/A24.1727.1825.92Price / Sales54.3760.66754.6383.33Price / CashN/A45.5327.0359.91Price / Book72.507.977.776.29Net Income-$19.15M$34.89M$199.14M$270.85M7 Day Performance-17.14%15.70%9.73%3.36%1 Month Performance-9.94%14.32%20.13%6.41%1 Year PerformanceN/A106.56%68.51%28.26% SS Innovations International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SSIISS Innovations InternationalN/A$5.80-7.9%N/AN/A$1.12B$20.65M0.004Gap DownGKOSGlaukos4.7181 of 5 stars$93.73+4.0%$127.42+35.9%-30.3%$5.17B$432.95M-56.81780News CoveragePositive NewsAnalyst ForecastBLCOBausch + Lomb2.091 of 5 stars$14.99+2.8%$15.56+3.7%-3.2%$5.16B$4.79B-19.2213,500News CoveragePositive NewsSLNOSoleno Therapeutics4.442 of 5 stars$69.77+0.3%$115.09+65.0%+16.8%$3.70BN/A-16.8530Trending NewsAnalyst UpgradeShort Interest ↑Analyst RevisionTMDXTransMedics Group2.8636 of 5 stars$104.010.0%$122.11+17.4%-18.6%$3.55B$441.54M53.89210NVSTEnvista3.9308 of 5 stars$21.29+2.4%$20.92-1.7%+22.5%$3.45B$2.51B66.5212,300Positive NewsLIVNLivaNova2.9117 of 5 stars$57.97-0.3%$59.71+3.0%+20.8%$3.18B$1.25B-14.902,900Positive NewsWRBYWarby Parker1.6922 of 5 stars$26.02+2.6%$24.06-7.5%+96.3%$2.67B$771.32M-371.593,780Positive NewsInsider TradeINSPInspire Medical Systems4.9024 of 5 stars$86.40+0.1%$164.50+90.4%-60.0%$2.55B$802.80M49.941,246Positive NewsLQDALiquidia Technologies3.7953 of 5 stars$28.85+0.0%$32.11+11.3%+166.0%$2.48B$14M-16.9750Positive NewsLMATLeMaitre Vascular3.0999 of 5 stars$97.49+0.4%$97.60+0.1%+8.6%$2.20B$219.86M47.33490Positive News Related Companies and Tools Related Companies Glaukos Alternatives Bausch + Lomb Alternatives Soleno Therapeutics Alternatives TransMedics Group Alternatives Envista Alternatives LivaNova Alternatives Warby Parker Alternatives Inspire Medical Systems Alternatives Liquidia Technologies Alternatives LeMaitre Vascular Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SSII) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SS Innovations International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SS Innovations International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
